Owing to activation of ACE2-ANG-(1-7)-MA axis having therapeutic potential in established hypertension and kidney disease, there is an ongoing need for additional study to elucidate its reprogramming effects in renal programming. This evidence concerns the gene ACE2 and hypertensive disorder.